[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0303220D0 - New process - Google Patents

New process

Info

Publication number
SE0303220D0
SE0303220D0 SE0303220A SE0303220A SE0303220D0 SE 0303220 D0 SE0303220 D0 SE 0303220D0 SE 0303220 A SE0303220 A SE 0303220A SE 0303220 A SE0303220 A SE 0303220A SE 0303220 D0 SE0303220 D0 SE 0303220D0
Authority
SE
Sweden
Prior art keywords
mandelic acid
alkyl
acid derivatives
formula iia
new process
Prior art date
Application number
SE0303220A
Other languages
English (en)
Inventor
Kurt Voegtli
Andrea Zistler
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303220A priority Critical patent/SE0303220D0/sv
Publication of SE0303220D0 publication Critical patent/SE0303220D0/sv
Priority to CA002546694A priority patent/CA2546694A1/en
Priority to EP04819714A priority patent/EP1692089A2/en
Priority to PCT/GB2004/004964 priority patent/WO2005054168A2/en
Priority to BRPI0416931-0A priority patent/BRPI0416931A/pt
Priority to AU2004295152A priority patent/AU2004295152B2/en
Priority to NZ547354A priority patent/NZ547354A/en
Priority to US10/579,854 priority patent/US7960582B2/en
Priority to JP2006540610A priority patent/JP4906511B2/ja
Priority to SG200808873-4A priority patent/SG148212A1/en
Priority to KR1020067012985A priority patent/KR101134767B1/ko
Priority to CNA2008101754369A priority patent/CN101407453A/zh
Priority to SG200808874-2A priority patent/SG148213A1/en
Priority to CNB2004800349394A priority patent/CN100448834C/zh
Priority to IL175488A priority patent/IL175488A/en
Priority to NO20062258A priority patent/NO20062258L/no
Priority to ZA200604192A priority patent/ZA200604192B/en
Priority to AU2009208107A priority patent/AU2009208107A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/20Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
SE0303220A 2003-11-28 2003-11-28 New process SE0303220D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0303220A SE0303220D0 (sv) 2003-11-28 2003-11-28 New process
CNB2004800349394A CN100448834C (zh) 2003-11-28 2004-11-25 通过与手性碱环酰胺形成盐而拆分任选取代的扁桃酸的方法
JP2006540610A JP4906511B2 (ja) 2003-11-28 2004-11-25 キラルな塩基環状アミドとの塩形成による、場合により置換されたマンデル酸を分割するための方法
KR1020067012985A KR101134767B1 (ko) 2003-11-28 2004-11-25 키랄 염기 환형 아미드와의 염 형성에 의해, 임의로 치환된 만델산을 분할하는 방법
PCT/GB2004/004964 WO2005054168A2 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
BRPI0416931-0A BRPI0416931A (pt) 2003-11-28 2004-11-25 processo para resolver ácidos mandélicos, e, composto
AU2004295152A AU2004295152B2 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
NZ547354A NZ547354A (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
US10/579,854 US7960582B2 (en) 2003-11-28 2004-11-25 Process for the preparation and resolution of mandelic acid derivatives
CA002546694A CA2546694A1 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
SG200808873-4A SG148212A1 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
EP04819714A EP1692089A2 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
CNA2008101754369A CN101407453A (zh) 2003-11-28 2004-11-25 通过与手性碱环酰胺形成盐而拆分任选取代的扁桃酸的方法
SG200808874-2A SG148213A1 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
IL175488A IL175488A (en) 2003-11-28 2006-05-08 Process for resolving optionally substituted mandelic acids by salt formation with a chiral base cyclic amide
NO20062258A NO20062258L (no) 2003-11-28 2006-05-19 Nye metoder
ZA200604192A ZA200604192B (en) 2003-11-28 2006-05-24 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
AU2009208107A AU2009208107A1 (en) 2003-11-28 2009-08-11 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303220A SE0303220D0 (sv) 2003-11-28 2003-11-28 New process

Publications (1)

Publication Number Publication Date
SE0303220D0 true SE0303220D0 (sv) 2003-11-28

Family

ID=29729226

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303220A SE0303220D0 (sv) 2003-11-28 2003-11-28 New process

Country Status (15)

Country Link
US (1) US7960582B2 (sv)
EP (1) EP1692089A2 (sv)
JP (1) JP4906511B2 (sv)
KR (1) KR101134767B1 (sv)
CN (2) CN101407453A (sv)
AU (2) AU2004295152B2 (sv)
BR (1) BRPI0416931A (sv)
CA (1) CA2546694A1 (sv)
IL (1) IL175488A (sv)
NO (1) NO20062258L (sv)
NZ (1) NZ547354A (sv)
SE (1) SE0303220D0 (sv)
SG (2) SG148213A1 (sv)
WO (1) WO2005054168A2 (sv)
ZA (1) ZA200604192B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
SE0303220D0 (sv) 2003-11-28 2003-11-28 Astrazeneca Ab New process
GB0510546D0 (en) * 2005-05-24 2005-06-29 Astrazeneca Ab New process
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
TW200900033A (en) * 2007-06-21 2009-01-01 Wen-Qing Li Automatic brewing machine
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
CN103450008B (zh) * 2013-09-02 2015-02-25 江苏宝众宝达药业有限公司 一种从废水中回收扁桃酸的方法
CN104447294A (zh) * 2014-11-24 2015-03-25 苏州乔纳森新材料科技有限公司 一种3-环己烯-1-甲酸的手性拆分方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1867274A (en) * 1929-11-20 1932-07-12 Lilly Co Eli Resolution of ephedrine and its homologues and of mandelic acid, and certain intermediates
JPS581105B2 (ja) * 1977-03-24 1983-01-10 日本化薬株式会社 光学活性アミノ酸−マンデル酸複合体及びその製造法
JPS5416442A (en) * 1977-07-08 1979-02-07 Sumitomo Chem Co Ltd Optical resolution of 3-pheoxymandelic acid
US4239912A (en) * 1978-12-08 1980-12-16 American Cyanamid Company Process for resolving DL-Mandelic acid with novel 2-benzylamino-1-butanols
US4260815A (en) * 1979-10-09 1981-04-07 American Cyanamid Company Process for preparing a solution of DL-mandelic acid
US4259521A (en) * 1979-10-09 1981-03-31 American Cyanamid Company Process for resolving DL-mandelic acid
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
DE4137663A1 (de) * 1991-11-12 1993-05-13 Degussa Verfahren zur herstellung optisch aktiver 1,3-imidazolidin-4-one und deren verwendung
JPH11228546A (ja) * 1998-02-09 1999-08-24 Koei Chem Co Ltd 光学活性2−(N−tert−ブチルカルバモイル)ピペラジンの製造法
JP2001002641A (ja) * 1999-06-24 2001-01-09 Daito Chemix Corp 光学活性3−アミノピロリジン−2−オン誘導体の製造法
JP2001072644A (ja) 1999-09-06 2001-03-21 Yamakawa Yakuhin Kogyo Kk 光学活性な2−クロロマンデル酸の製造方法および製造の中間体
JP3960801B2 (ja) 1999-11-29 2007-08-15 三菱レイヨン株式会社 アセタールスルホネート誘導体およびその製造方法ならびにスチレンオキサイド誘導体の製造方法
EP1341762A1 (en) 2000-11-20 2003-09-10 Eli Lilly And Company Process for resolving racemic mixtures of piperidine derivatives
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0303220D0 (sv) 2003-11-28 2003-11-28 Astrazeneca Ab New process
GB0503672D0 (en) * 2005-02-23 2005-03-30 Astrazeneca Ab New process
GB0510546D0 (en) * 2005-05-24 2005-06-29 Astrazeneca Ab New process

Also Published As

Publication number Publication date
CA2546694A1 (en) 2005-06-16
CN101407453A (zh) 2009-04-15
AU2009208107A1 (en) 2009-09-03
US7960582B2 (en) 2011-06-14
CN1886359A (zh) 2006-12-27
JP2007513885A (ja) 2007-05-31
WO2005054168A2 (en) 2005-06-16
WO2005054168A3 (en) 2005-10-27
KR101134767B1 (ko) 2012-04-13
IL175488A (en) 2012-02-29
IL175488A0 (en) 2006-09-05
SG148213A1 (en) 2008-12-31
AU2004295152B2 (en) 2009-07-02
JP4906511B2 (ja) 2012-03-28
AU2004295152A1 (en) 2005-06-16
EP1692089A2 (en) 2006-08-23
BRPI0416931A (pt) 2007-01-16
SG148212A1 (en) 2008-12-31
NZ547354A (en) 2010-02-26
KR20060109965A (ko) 2006-10-23
US20080312457A1 (en) 2008-12-18
CN100448834C (zh) 2009-01-07
ZA200604192B (en) 2007-11-28
NO20062258L (no) 2006-08-23

Similar Documents

Publication Publication Date Title
TW200722415A (en) New process
NO20062258L (no) Nye metoder
HRP20040690B1 (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
RS53398B (en) PROCEDURE FOR OBTAINING AMINO CROTONYL UNITS
BR0316902A (pt) Processos para preparar (+)duloxetina e hidrocloreto de (+)duloxetina, sal de ácido quiral e (+)duloxetina, di-p-toluil tartarato de (+)duloxetina, (+)duloxetina e composição farmacêutica
EA200501477A1 (ru) Производные пиперидинил- и пиперазинилалкилкарбаматов, способы их получения и применение их в терапии
TW200600508A (en) Cyclic amide derivative, and its production and use
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
HRP20040977B1 (en) Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
ATE441627T1 (de) Verfahren zur herstellung von valsartan
CY1111277T1 (el) Μεθοδος παραγωγης κιλοσταζολης
AR074128A1 (es) Derivados de 4-[2-(2-fluorofenoximetil)fenil] piperidina, composiciones farmaceuticas que los contienen, metodo de preparacion, compuestos intermediarios de dicho proceso y uso de los mismos para el tratamiento de dolores neuropaticos, mal de alzheimer y otras enfermedades relacionadas con el snc.
KR910021366A (ko) 4-(4-알콕시페닐)-2-부틸아민 유도체 및 그의 제조방법
BRPI0415220A (pt) processo de produção de amida carboxìlica e derivados da mesma
RU2002130710A (ru) Производное пиридин-1-оксида и способ его преобразования в фармацевтически эффективные соединения
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
AR037387A1 (es) Proceso para la preparacion de amidas de acido alfa-hidroxicarboxilico
RS54082B1 (en) PROCEDURE FOR ENZYMIC SYNTHESIS (7S) -1- (3,4-DIMETOXYBICYCLO [4.2.0] OCTA-1,3,5-TRIEN-7-IL) N-METHYL METHANAMINE AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND ITS SALTS
TW200637856A (en) Process for producing thiazolidinedion compound and intermediate thereof
BRPI0516192A (pt) composto, e, método para a preparação de um composto
TW200604161A (en) Chemical process
ATE455088T1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
MX2023003496A (es) Un proceso para la sintesis de compuestos antranilicos de acido/amida e intermedios de los mismos.
MX2023014235A (es) Un proceso novedoso para la preparacion de diamidas antranilicas.
ATE555095T1 (de) Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga